Eli Lilly Inks ~2.5B Deal to Acquire Scorpion Therapeutics
Shots: Eli Lilly to acquire Scorpion, plus its leading asset STX-478, for ~2.5B in...
Johnson & Johnson to Acquire Intra-Cellular Therapies for ~14.6B, Boosting its Neuroscience Portfolio
Shots: J&J entered into a definitive agreement to acquire Intra-Cellular Thera...
GSK to Acquire IDRx for ~1.15B, Boosting its GI Cancer Portfolio
Shots: GSK to acquire IDRx incl. its lead candidate IDRX-42, for $1B upfront &...
Veralox Therapeutics to Acquire Nudge Therapeutics, Expanding its Portfolio
Shots: Veralox has signed an exclusive agreement to acquire Nudge Therapeutic...
Transcarent to Acquire Accolade for ~$621M
Shots: Transcarent to acquire Accolade with a total equity value of ~$621M, with s...
Vividion Therapeutics to Bolster its Genomic Abilities Through the Acquisition of Tavros Therapeutics
Shots: Vividion (Bayer’s subsidiary) has acquired Tavros to strengthen its g...
